Literature DB >> 23798496

Altered Ca2+ concentration, permeability and buffering in the myofibre Ca2+ store of a mouse model of malignant hyperthermia.

Carlo Manno1, Lourdes Figueroa, Leandro Royer, Sandrine Pouvreau, Chang Seok Lee, Pompeo Volpe, Alessandra Nori, Jingsong Zhou, Gerhard Meissner, Susan L Hamilton, Eduardo Ríos.   

Abstract

Malignant hyperthermia (MH) is linked to mutations in the type 1 ryanodine receptor, RyR1, the Ca2+ channel of the sarcoplasmic reticulum (SR) of skeletal muscle. The Y522S MH mutation was studied for its complex presentation, which includes structurally and functionally altered cell 'cores'. Imaging cytosolic and intra-SR [Ca2+] in muscle cells of heterozygous YS mice we determined Ca2+ release flux activated by clamp depolarization, permeability (P) of the SR membrane (ratio of flux and [Ca2+] gradient) and SR Ca2+ buffering power (B). In YS cells resting [Ca2+]SR was 45% of the value in normal littermates (WT). P was more than doubled, so that initial flux was normal. Measuring [Ca2+]SR(t) revealed dynamic changes in B(t). The alterations were similar to those caused by cytosolic BAPTA, which promotes release by hampering Ca2+-dependent inactivation (CDI). The [Ca2+] transients showed abnormal 'breaks', decaying phases after an initial rise, traced to a collapse in flux and P. Similar breaks occurred in WT myofibres with calsequestrin reduced by siRNA; calsequestrin content, however, was normal in YS muscle. Thus, the Y522S mutation causes greater openness of the RyR1, lowers resting [Ca2+]SR and alters SR Ca2+ buffering in a way that copies the functional instability observed upon reduction of calsequestrin content. The similarities with the effects of BAPTA suggest that the mutation, occurring near the cytosolic vestibule of the channel, reduces CDI as one of its primary effects. The unstable SR buffering, mimicked by silencing of calsequestrin, may help precipitate the loss of Ca2+ control that defines a fulminant MH event.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23798496      PMCID: PMC3784192          DOI: 10.1113/jphysiol.2013.259572

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  63 in total

1.  Knocking down type 2 but not type 1 calsequestrin reduces calcium sequestration and release in C2C12 skeletal muscle myotubes.

Authors:  Ying Wang; Le Xu; Hongzhe Duan; Daniel A Pasek; Jerry P Eu; Gerhard Meissner
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

2.  Ca2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin.

Authors:  R D Mitchell; H K Simmerman; L R Jones
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

3.  A general procedure for determining the rate of calcium release from the sarcoplasmic reticulum in skeletal muscle fibers.

Authors:  W Melzer; E Rios; M F Schneider
Journal:  Biophys J       Date:  1987-06       Impact factor: 4.033

4.  How source content determines intracellular Ca2+ release kinetics. Simultaneous measurement of [Ca2+] transients and [H+] displacement in skeletal muscle.

Authors:  Gonzalo Pizarro; Eduardo Ríos
Journal:  J Gen Physiol       Date:  2004-09       Impact factor: 4.086

5.  Effect of sarcoplasmic reticulum Ca2+ content on action potential-induced Ca2+ release in rat skeletal muscle fibres.

Authors:  G S Posterino; G D Lamb
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

6.  Voltage-dependent Ca2+ fluxes in skeletal myotubes determined using a removal model analysis.

Authors:  R P Schuhmeier; W Melzer
Journal:  J Gen Physiol       Date:  2003-12-15       Impact factor: 4.086

7.  A caffeine- and ryanodine-sensitive Ca2+ store in bullfrog sympathetic neurones modulates effects of Ca2+ entry on [Ca2+]i.

Authors:  D D Friel; R W Tsien
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

8.  A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.

Authors:  Zoita Andronache; Susan L Hamilton; Robert T Dirksen; Werner Melzer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

9.  D4cpv-calsequestrin: a sensitive ratiometric biosensor accurately targeted to the calcium store of skeletal muscle.

Authors:  Monika Sztretye; Jianxun Yi; Lourdes Figueroa; Jingsong Zhou; Leandro Royer; Eduardo Ríos
Journal:  J Gen Physiol       Date:  2011-08       Impact factor: 4.086

10.  Measurement of RyR permeability reveals a role of calsequestrin in termination of SR Ca(2+) release in skeletal muscle.

Authors:  Monika Sztretye; Jianxun Yi; Lourdes Figueroa; Jingsong Zhou; Leandro Royer; Paul Allen; Gustavo Brum; Eduardo Ríos
Journal:  J Gen Physiol       Date:  2011-08       Impact factor: 4.086

View more
  19 in total

1.  CaATP prolongs strong actomyosin binding and promotes futile myosin stroke.

Authors:  Jinghua Ge; Akhil Gargey; Irina V Nesmelova; Yuri E Nesmelov
Journal:  J Muscle Res Cell Motil       Date:  2019-09-25       Impact factor: 2.698

2.  Ca2+ influx via the Na+/Ca2+ exchanger is enhanced in malignant hyperthermia skeletal muscle.

Authors:  Francisco Altamirano; José M Eltit; Gaëlle Robin; Nancy Linares; Xudong Ding; Isaac N Pessah; Paul D Allen; José R López
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

3.  Malignant hyperthermia: to buffer or not to buffer.

Authors:  Meghna Pant; Danesh H Sopariwala; Naresh C Bal
Journal:  J Physiol       Date:  2014-03-01       Impact factor: 5.182

Review 4.  Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease.

Authors:  Antonio Michelucci; Maricela García-Castañeda; Simona Boncompagni; Robert T Dirksen
Journal:  Cell Calcium       Date:  2018-10-30       Impact factor: 6.817

5.  Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.

Authors:  Wenqian Chen; Andrea Koop; Yingjie Liu; Wenting Guo; Jinhong Wei; Ruiwu Wang; David H MacLennan; Robert T Dirksen; Sui Rong Wayne Chen
Journal:  Biochem J       Date:  2017-08-07       Impact factor: 3.857

6.  Molecular mechanism of the severe MH/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM.

Authors:  Kavita A Iyer; Yifan Hu; Thomas Klose; Takashi Murayama; Montserrat Samsó
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779

7.  Activation and propagation of Ca2+ release from inside the sarcoplasmic reticulum network of mammalian skeletal muscle.

Authors:  Tanya R Cully; Joshua N Edwards; Bradley S Launikonis
Journal:  J Physiol       Date:  2014-06-27       Impact factor: 5.182

8.  Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region.

Authors:  Takashi Murayama; Nagomi Kurebayashi; Toshiko Yamazawa; Hideto Oyamada; Junji Suzuki; Kazunori Kanemaru; Katsuji Oguchi; Masamitsu Iino; Takashi Sakurai
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

9.  Dampened activity of ryanodine receptor channels in mutant skeletal muscle lacking TRIC-A.

Authors:  Sam El-Ajouz; Elisa Venturi; Katja Witschas; Matthew Beech; Abigail D Wilson; Chris Lindsay; David Eberhardt; Fiona O'Brien; Tsunaki Iida; Miyuki Nishi; Hiroshi Takeshima; Rebecca Sitsapesan
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

Review 10.  The disorders of the calcium release unit of skeletal muscles: what have we learned from mouse models?

Authors:  Marta Canato; Paola Capitanio; Carlo Reggiani; Lina Cancellara
Journal:  J Muscle Res Cell Motil       Date:  2014-11-26       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.